Patent · US Active

Methods and compositions for the inhibition of Pin1

US9730941B2 · kind B2 · utility

1Cited by

23References

3Claims

0Family size

Assignees

Beth Israel Deaconess Medical Center, Inc. · US
The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Kun Ping Lu · Newton, US
Matthew B. Boxer · Point of Rocks, US
Mindy Irene Emily Davis · Rockville, US
Rajan Pragani · Rockville, US
Min-Jui Richard Shen · Boyds, US
Anton Simeonov · Rockville, US
Shuo Wei · Sharon, US
Xiao Zhen Zhou · Newton, US

Key dates

Filing date	Jun 7, 2013
Grant date	Aug 15, 2017
Priority date	—
Expiry date	Nov 3, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention features compositions and methods for inhibiting the Pin1 protein, and the treatment of disorders characterized by elevated Pin1 levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.